Exhibit 99.1



Angeion Corporation
  350
  Oak Grove Parkway
  St.
  Paul, MN 55127 USA
  Telephone:
  (651) 484-4874
  Facsimile: (651) 484-4826




FOR IMMEDIATE RELEASE

Angeion Corporation Announces Increase in
Stock Repurchase Program



ST. PAUL, Minn. — (September 13,
2010) — Angeion Corporation (NASDAQ: ANGN) today announced that its Board of Directors
has approved an increase in the Company’s stock repurchase program.  Under the
amended plan, the Company is authorized to purchase up to $2 million worth of
its outstanding shares of common stock in the open market or in privately
negotiated transactions between now and April 30, 2011.

Rodney A. Young, Angeion’s
president and chief executive officer, said the Board increased the repurchase
program due to the stock’s current price level and Angeion’s continued strong
capital position.  Young stated: “We believe repurchasing our shares represents
an attractive investment opportunity that will benefit the Company and our
shareholders.  The larger repurchase program will not affect our ability to
continue to invest in growth initiatives that are key to our future success.”

Angeion intends to make its
public purchases in compliance with SEC Rule 10b-18.  Under that rule, Angeion
may purchase shares in the open market or in privately negotiated
transactions.  Open market purchases are limited, in any single day, to 25% of
the average daily trading volume for the prior four calendar weeks.  The
average daily trading volume for the four weeks ended September 10, 2010 was
4,581 shares.  This would allow Angeion to purchase a total of 1,145 shares per
day through open market purchases.  Repurchases through privately negotiated
transactions are not subject to these restrictions.

On March 16, 2010, Angeion had
previously announced its intention to purchase up to $1 million of its common
stock.  Through September 10, 2010, Angeion had bought back a total of 65,249
shares at a cost of $299,000.  Now the total amount remaining authorized for
purchase under the revised program is approximately $1.7 million.

The timing and actual number of
shares purchased will depend upon a variety of factors, such as price,
corporate and regulatory requirements, alternative investment opportunities,
and other market and economic conditions.  Angeion will fund repurchases from
its available working capital.  This program may be started, suspended or
terminated at any time, or from time to time at management’s discretion without
prior notice.

As of July 31, 2010, Angeion
had cash and investments of $10.3 million, shareholders’ equity of $15.5
million and had 4,135,009 shares outstanding.

(more)

1


---



About Angeion Corporation Founded in 1986, Angeion Corporation acquired Medical
Graphics Corporation in December 1999.  Medical Graphics develops, manufactures
and markets non-invasive cardiorespiratory diagnostic systems that are sold
under the MedGraphics (www.medgraphics.com)and New Leaf (www.newleaffitness.com)brand
and trade names.  These cardiorespiratory diagnostic systems have a wide range
of applications in healthcare as well as health and fitness. The Company’s
products are sold internationally through distributors and in the United States
through a direct sales force that targets heart and lung specialists located in
hospitals, university-based medical centers, medical clinics and physicians’
offices, pharmaceutical companies, medical device manufacturers, clinical
research organizations, health and fitness clubs, personal training studios,
and other exercise facilities.  For more information about Angeion, visitwww.angeion.com.  Contact:
 Rodney A. Young, President and Chief Executive Officer, or
  Larry Degen,
  Interim Chief Financial Officer at (651) 484-4874
  ###  2


---